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Background: Embryonic stem cells (ESCs) are pluripotent stem cells and can differentiate into cardiomyocytes
when cultured in appropriate conditions. The function of hypoxia-inducible factors (HIFs) has been identified in
directing the formation of cardiac lineages. The purpose of this study was to investigate the ability of HIF2α to
induce differentiation of ESCs into cardiomyocytes and to explore the potential underlying molecular mechanisms.
Methods: Cardiac differentiation from mouse ESCs was analyzed using the “hanging drop” method, and success
was determined by assaying the numbers of beating embryoid bodies and the expression level of cardiac markers.
The expression of HIF2α was then manipulated during cardiac differentiation with piggyBac transposon and the
lentivirus system. The underlying mechanism was finally examined via administering selective inhibitors of the
Wnt/β-catenin signaling pathway.
Results: Overexpressing HIF2α can significantly drive mouse ESCs to form cardiomyocytes. Contrarily, knockdown of
HIF2α inhibits the emergence of cardiac cells. In addition, the cardiomyogenesis-promoting effect of HIF2α occurred
by increasing the protein level of β-catenin, an effector that contributes to cardiac differentiation at an early stage
of ESC differentiation.
Conclusion: HIF2α has a cardiomyogenesis-promoting effect in ESCs via enhancing the activation of the Wnt/β-catenin
signaling pathway. Our results may be beneficial for generating and applying cardiomyocytes from ESCs safely and
effectively in the future.
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Cardiomyogenic development is a multistep process
involving a cascade of signaling events and multiple
transcription factors, which operate in a spatial and
temporal fashion to specify the fate of cardiac cells [1].
Unfortunately, our current understanding of cardio-
myogenesis is limited due to the difficulty of studying
cardiac specification effectively in vivo. In vitro manipula-
tion of embryonic stem cells (ESCs) to form embryoid
bodies (EBs) that consistently give rise to beating cardio-
myocytes has become a useful model for exploring the
structural and functional properties of cardiomyogenesis
[2]. ESCs are derived from the inner cell mass of pre-
implantation blastocysts and can be maintained in culture
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become an attractive candidate cell source to obtain
enough cardiomyocytes for cardiac repair, such as after
myocardial infarction, which is characterized by the loss
of functional cardiomyocytes [5]. However, the molecular
mechanisms governing differentiation of ESCs into cardio-
myocytes are still poorly understood.
Cardiac fate decisions are influenced by many parame-
ters, such as FGF [6], Notch [7], Wnt [8] signaling path-
ways, GATA transcription factors [9] and hypoxia
conditions [10]. Actually, hypoxia is involved the natural
progression of organogenesis in the early development
of mammals and is one of the most critical elements for
the formation of the heart [11]. Consistently, low oxygen
tension in vitro has been shown to enhance cardiac
differentiation from ESCs [12,13]. The pivotal regulators
of cellular responses to oxygen deprivation are hypoxia-
inducible factors (HIFs) [14], which are heterodimericis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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[14]. Of interest, HIF1α is more similar to HIF2α than
HIF3α in functional domains, expression patterns and
functions. Both HIF1α and HIF2α proteins contain the
basic-helix-loop-helix Per-ARNT-SIM domain (bHLH-
PAS), which is critical for gene binding. In addition, both
are widely expressed in various tissues. However, HIF3α
is normally expressed only in highly avascular tissues,
such as the cornea. Additionally, they activate gene
transcription while HIF3α inhibits the HIF1α- or
HIF2α-mediated hypoxia responses [14]. A previous
study demonstrated that HIF1α is essential for proper
cardiac differentiation because HIF1α deficiency leads
to abnormal cardiac looping in mice due to defective
ventricle formation caused by reduced expression of
myocyte factors [11]. Similarly, cultured ESCs in vitro
without HIF1α expression rarely form beating embry-
oid bodies (EBs) [15], while overexpression of HIF1α
can promote cardiac differentiation in mouse ECS-derived
EBs [16, 17]. Notably, both HIF1α and HIF2α protein
complexes are expressed in cardiac tissue [18]. However,
little is known about the role of HIF2α in cardiac
differentiation.
In this study, we investigated the role of HIF2α in
cardiac differentiation using gain- and loss-of-function
methods in mouse ESCs, and explored the possible
intracellular signaling pathways by which HIF2α acti-
vates this process. Our study might provide expanded
insight to create an effective strategy for promoting dif-
ferentiation of ESCs cells into cardiomyocytes.
Methods
Mouse ESC culture
46C ESCs, kindly provided by Dr. Smith A (University of
Cambridge), were cultured on 0.1% gelatin-coated dishes
at 37°C in 5% CO2. The medium for routine main-
tenance was GMEM (Sigma, G5414) supplemented
with 10% FCS (HyClone), 1% MEM nonessential amino
acids (Invitrogen), 2 mM GlutaMax (Invitrogen), 0.1 mM
β-mercaptoethanol (Invitrogen) and 100 units/ml LIF
(Millipore). Cells were digested by 0.25% trypsin (Invitro-
gen) and passaged when confluence reached approxi-
mately 70%.
Cardiac differentiation of ESCs
ESCs were differentiated into beating cardiomyocytes
in vitro by the “hanging drop” method as described pre-
viously [19]. Briefly, the modified steps included with-
drawal of LIF and cultivation of 1,000 cells in 30 μL
hanging drops to produce EBs for two days. After two
days, the EBs were seeded onto gelatin-coated 48-well
plates. The medium was renewed every two days. Over
the next two weeks, the beating rates of these EBs were
compared according to need.Plasmid construction and transfection
For RNA interference in ESCs, short hairpin (shRNA)
constructs for HIF2α were designed to target 21 base-
pair gene specific regions and were then amplified into
the pLKO.1-TRC (AgeI and EcoRI sites). The targeted
sequences are as follows: HIF2α sh#1:GCTTCCTTCG
GACACATAAGC; HIF2α sh#2: GGGACTTACTCAG
GTAGAACT. pLKO.1-TRC-based lentiviral vectors were
transfected into 293 T cells in combination with
pMD2.G and psPAX2 plasmids. Virus-containing
supernatant was collected after 48 hours and filtered
through 0.45 μm filters (Millipore). ESCs were incu-
bated in the virus supernatant for 48 hours. For gene
overexpression, the coding region of HIF2α was cloned
from mouse cDNA with Hot Start DNA Polymerase
(Takara) and was inserted into the BglП and SalI sites
of the PiggyBac transposon vectors. ESCs were trans-
fected with 2 μg PiggyBac inserted with targets plus a
2 μg transposon vector using Lipofectamine 2000
(Invitrogen) according to the manufacturer’s instruc-
tions. The modified cells were screened by treatment
with 2 μg/ml puromycin for about one week.
RT-PCR and qRT-PCR
Total RNA was extracted with TRIzol (Invitrogen).
cDNA was synthesized with 1 μg of total RNA using a
PrimeScript 1st strand cDNA Synthesis Kit (Takara) ac-
cording to the manufacturer’s instructions. QRT-PCR
was performed with SYBR® Premix Ex Taq™ (Takara) in
an ABI7500 Real-Time PCR machine (Applied Biosys-
tems). Target gene expression was normalized to
GAPDH expression. The primers that were used are
listed in Additional file 1: Table S1.
Western blotting
Cells were lysed in ice-cold RIPA cell buffer (Sigma)
supplemented with protease inhibitors (Sigma). The
proteins were separated with a 4–12% PAGE gel and
electrotransferred onto a PVDF membrane. The membrane
was probed with primary antibodies and subsequently de-
tected by horseradish-peroxidase (HRP) conjugated anti-
bodies (Santa Cruz). The primary antibodies were β-catenin
(Santa Cruz), Flag antibody (Sigma), HIF1α (Santa Cruz)
and HIF2α (Santa Cruz).
Luciferase reporter assay
TOP-Flash or FOP-Flash constructs (Addgene) were
co-transfected with a Renilla luciferase plasmid
(Promega) into mESCs overexpressing PB empty
vectors or PB-HIF2α plasmids. Cells were harvested
and the relative luciferase activity of the lysate was
measured with the Dual-Luciferase reporter assay system
(Promega).
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Cells were fixed in 4% paraformaldehyde for 20 minutes
and blocked in blocking buffer (PBS containing 5%
BSA and 0.2% Triton X-100). Cells were incubated in
primary antibody solution at 4°C overnight, followed
by Alexa Fluor 488 (Invitrogen, 1:1000) secondary anti-
bodies for 1 h at 37°C. Nuclei were stained with
Hoechst (Invitrogen, 1:10000). The primary antibodies
were Gata4 (G4; Santa Cruz, 1:100), Myosin (MF-20;
DSHB, 1:50) and Troponin T (1:1000, Abcam).
FACS analysis
Differentiated EBs were trypsinized into single cells,
fixed in 2% PFA and permeabilized with 0.2%
Triton × 100. Cells were suspended in antibody solu-
tion containing anti-cTnT and α-SMA antibodies
(1:200, Abcam). Cells were washed in PBS three times
and then resuspended in FITC-conjugated secondary
antibody solution (1:1000, Invitrogen). Cardiomyo-
cytes were detected with a BECKMAN COULTER
FACS.
Cobalt chloride (CoCl2) treatment
To induce a hypoxic condition, 100 μM CoCl2 (Sigma)
were supplemented into ESCs or EBs. For analyzing the
protein levels of HIF1α or HIF2α, 46C ESCs were
treated with or without 100 μM CoCl2 for 10 h. For in-
ducing cardiac differentiation, ESCs-derived EBs were
exposed to 100 μM CoCl2 during the whole process of
differentiation, and the medium was changed every two
days.
Statistical analysis
All data are reported as the mean ± s.d. A Student’s t test
was used to determine the significance of differences in
comparisons. Values of p < 0.05 were considered as sta-
tistically significant.
Results and discussion
HIF2a has no effect on the self-renewal of ESCs
A previous report showed that HIF1α is sufficient to
induce morphological changes reflective of the transi-
tion from ESCs to epiblast stem cells (EpiSCs) [20]. To
investigate the function of HIF2α in the self-renewal of
ESCs, mouse 46C ESCs were transfected with a piggy-
Bac vector encoding HIF2α and analyzed by western
blotting for expression of HIF2α (Figure 1A). There
was no obvious distinguishing characteristic in the
morphology of empty-vector control- and HIF2α-ESCs
(Figure 1B). Additionally, HIF2α did not affect the pro-
liferation of ESCs (Figure 1C) and the expression level
of key pluripotency genes Oct4, Sox2 and Nanog
(Figure 1D). These results indicated that HIF2α does
not affect the capacity for self-renewal of mouse ESCs.Expression pattern of HIF2a during cardiac differentiation
To examine the expression profile of HIF2α during car-
diac differentiation, we differentiated 46C ESCs into car-
diomyocytes, which were immunopositive for cardiac
markers Gata4, Myosin and Troponin T (Figure 2A),
and then total RNA from ESCs and different stages of
EBs (days 2, 4, 6, 8, and 10) were extracted and assessed
by quantitative RT-PCR (qRT-PCR). qRT-PCR analysis
showed that mRNA transcripts of pluripotency markers
Oct4 and Nanog were robust in undifferentiated mouse
ESCs, but declined abruptly upon induction of EB for-
mation (Figure 2B), while HIF2α was increased in differ-
entiating EBs from day 2 onward and reached a peak at
day 4 (Figure 2B), indicating that HIF2α may exert a role
at an early stage of cardiac differentiation.
HIF2α promotes cardiac differentiation of ESCs
Previous studies have shown that a hypoxic condition
has strong influence during the development of the car-
diovascular system, [17,21]. In line with this, hypoxia
(4% oxygen tension) yields more cardiomyocytes than
normoxic conditions in mouse and human ESCs [12,22].
As an important downstream target of hypoxia, we inves-
tigated the contribution of HIF2α in cardiomyogenesis.
We differentiated empty-vector control- and HIF2α-ESCs
into cardiomyocytes using the hanging drop method. The
colonies of beating EBs were counted from days 8 and 10.
As shown in Figure 3A, the incidence of beating EBs in
HIF2α-transduced cells was significantly higher than those
transduced with the empty-vector construct (Figure 3A),
suggesting exogenous HIF2α could increase the beating
frequency of EBs from ESCs.
To confirm HIF2α treatment could promote cardio-
myocyte differentiation of mouse ESCs, we detected the
expressions of cardiac specific transcription factors in
EBs at day 9 and found overexpression of HIF2α signifi-
cantly increased the expression of genetic markers of car-
diac progenitors; i.e., Gata4, Tbx5, Mesp1, Nkx2.5 and
Mef2C (Figure 3B).
To verify whether a full program of cardiomyogenesis oc-
curred in HIF2α-ESC-derived EBs, a quantitative analysis of
structural cardiomyocyte markers (i.e., α-MHC and cTnT)
was performed in EBs at day 15. Higher expression of α-
MHC and cTnT was observed in HIF2α-EBs compared
with empty vector-EBs (Figure 3C). Flow cytometry (FACS)
analysis was used to confirmed the cardiomyogenesis-
promoting effect of HIF2α by detecting the expression of
cTnT and α-SMA at day 15 (Figure 3D). Collectively, these
results suggested that HIF2α is involved in cardiomyogen-
esis and regulates cardiac-specific transcription factors.
HIF2α knockdown suppresses key cardiac gene expression
To test whether HIF2α knockdown has an effect on
cardiac differentiation of ESCs, we infected 46C ESCs
Figure 1 The effect of HIF2α on the self-renewal of mouse ESCs. (A) Western blot analysis of 46C mouse ESCs overexpressing empty vectors
or Flag-tagged HIF2α. (B) Morphology of mouse ESCs transfected with empty or Flag-tagged HIF2α vectors and cultured in serum/LIF for five
passages. Scale bar, 100 μm. (C) Cell growth assay. Relative cell proliferation was measured as a standard at Days 0, 2, 4 and 6. The original cell
density was 3,000/well. Data represent the mean ± s.d. of three biological replicates. (D) Quantitative RT-PCR (qRT-PCR) analysis of Oct4, Sox2 and
Nanog in mouse ESCs transfected empty- or Flag-tagged HIF2α vectors. Data represent the mean ± s.d. of three biological replicates.
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(shRNAs) specific for HIF2α mRNA (shHIF2α). Stable
knockdown of HIF2α transcript levels was observed
following drug selection (Figure 4A). The percentage
of beating EBs in HIF2α knockdown cells was lowerFigure 2 Expression profile of HIF2α during cardiac differentiation. (A
Troponin T in mouse ESC-derived EBs at day 10. Scale bar, 100 μm. (B) qRT
days of ESCs-derived EBs. Data represent the mean ± s.d. of three biologicathan scrambled shRNA control cells (Figure 4B).
shHIF2α EBs showed decreased expression of cardiac
markers (Figure 4C), indicating that endogenous HIF2α
is important for the formation of cardiac lineages in
ESCs.) Immunostaining for cardiomyocyte markers Gata4, Myosin and
-PCR analysis of Oct4, Nanog and HIF2α in mouse ESCs and different
l replicates. *p < 0.05, **p < 0.01 vs ESCs.
Figure 3 HIF2α facilitated cardiac differentiation of ESCs. (A) The percentages of beating EBs derived from PB and PB-HIF2α mouse ESCs. Data
represent the mean ± s.d. of three biological replicates. **p < 0.01 vs PB. (B) qRT-PCR analysis of Gata4, Tbx3, Mesp1, Nkx2.5 and Mef2c in PB and
PB-HIF2α EBs at day 9. Data represent the mean ± s.d. of three biological replicates. *p < 0.05, **p < 0.01 vs PB. (C) qRT-PCR analysis of α-MHC
and cTnT in PB- and PB-HIF2α EBs at day 15. Data represent the mean ± s.d. of three biological replicates. *p < 0.05, **p < 0.01 vs PB. (D) The
differentiated cardiomyocytes from PB- and PB-HIF2α mouse ESCs were analyzed by FACS with cTnT and α-SMA staining.
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promoting effect of hypoxia
Because hypoxia is able to induce the stabilized HIF2α
protein [14], we next aimed to examine whether HIF2α
is involved in the cardiac differentiation-promoting ef-
fect of hypoxia in ESCs. CoCl2 is known to elicit
hypoxia-like responses [23], thereby we applied CoCl2 to
chemically mimic the hypoxia-like environment during
cardiac differentiation. As shown in Figure 5, 100 μM
CoCl2 could significantly enhance the rate of beating
EBs and the expression level of cardiac marker genes
(Figures 5A and B), while knockdown of HIF2α im-
paired, albeit not totally, the promoting-effect of CoCl2
on cardiac differentiation (Figures 5A and B), indicatingHIF2α partly mediated the potential cardiogenic effects
of hypoxia on cultured ESCs, similar to HIF1α [16].
Recent studies showed areas of induction of HIF2α to
a large extent overlapped with those for HIF1α in
response to hypoxia and both proteins were expressed in
the heart [18]. Moreover, a marked and persistent nu-
clear accumulation of both subunits has been observed
in cardiomyocytes under systemic and regional hypoxia
[24]. In addition, the hypoxic induction of HIF1α and
HIF2α in isolated cardiac microvascular endothelial cells
was very similar [25]. The above results indicated HIF1α
and HIF2α may be functionally redundant. Consistently,
we observed that 100 μM CoCl2 was able to increase
the protein levels of HIF1α and HIF2α (Figure 5C).
Figure 4 Knockdown of HIF2α impairs the ability of ESCs for cardiac differentiation. (A) qRT-PCR analysis of HIF2α mRNA levels in mouse
ESCs stably transfected with HIF2α shRNA. The transcript level was normalized against scramble shRNA controls. Data represent the mean ± s.d. of
three biological replicates. *p < 0.05, **p < 0.01 vs Scramble. (B) The percentages of beating EBs derived from scramble shRNA or shHIF2α ESCs.
Data represent the mean ± s.d. of three biological replicates. **p < 0.01 vs Scramble. (C) qRT-PCR analysis of cardiomyocyte-associated gene
(Gata4, Nkx2.5, Tbx5, Mesp1, Mef2C, α-MHC and cTnT) expression in shHIF2α ESC-derived EBs. Transcript levels were normalized against scramble
shRNA controls. Data represent the mean ± s.d. of three biological replicates. *p < 0.05, **p < 0.01 vs Scramble.
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cantly impaired the promoting-effect of CoCl2 on car-
diac differentiation (Figures 5E and D). However, it is
worthy to note that both factors were not totally com-
pensatory during development. For example, HIF2α
protein was stabilized in type II pneumocytes and pul-
monary endothelial cells in response to hypoxia, while
HIF1α was not detectable [26,27]. In addition, analysis
of HIF-α-staining patterns in ischemic myocardium
showed that both micro- and macrovascular endothelial
cells more frequently expressed HIF2α than HIF1α, and
a progressive increase of HIF2α but not HIF1α occurred
in myocardial tissue remote from the infarcted areas[24]. Furthermore, in the process of reprogramming,
continuous and prolonged overexpression of HIF1α is
beneficial for inducible pluripotent cell formation, while
HIF2α has a stage-specific function in the process, which
is essential in early, but not late, reprogramming [28]. It
is of great interest to undertake more experiments to
identify the specific functional redundancy between
HIF1α and HIF2α during cardiac development.
HIF2α promotes cardiac differentiation of ESCs via
β-catenin activation
A previous study reported that activation of the Wnt/β-
catenin signaling pathway at an early stage of ESC
Figure 5 HIF2α mediated the function of hypoxia in promoting cardiac differentiation. (A) The percentages of beating EBs derived from
scramble shRNA or shHIF2α ESCs in the presence of absence of 100 μm CoCl2. Data represent the mean ± s.d. of three biological replicates.
*p < 0.05, **p < 0.01 vs Scramble-NT. NT: No Treatment. (B) qRT-PCR analysis of Gata4 and Nkx2.5 mRNA levels in scramble shRNA or shHIF2α EBs
treated with or without CoCl2. Data represent the mean ± s.d. of three biological replicates. *p < 0.05, **p < 0.01 vs Scramble-NT. NT: No Treatment. (C)
Western blot analysis of the protein levels of HIF1α or HIF2α in 46C mouse ESCs treated with or without 100 μM CoCl2 for 10 h. (D) qRT-PCR analysis
of HIF1α or HIF2α mRNA levels in HIF1α and HIF2α double knockdown ESCs. Data represent the mean ± s.d. of three biological replicates. **p < 0.01 vs
Scramble. (E) The beating frequency of EBs was analyzed among the indicated groups at day 15. Data represent the mean ± s.d. of three biological
replicates. **p < 0.01 vs Scramble-NT.
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increase cardiac differentiation [8]. In addition, hypoxia
has been shown to be involved in activation of the
Wnt/β-catenin signaling pathway [29,30]. To determine
whether this pathway is modulated by HIF2α, we transi-
ently transfected empty vector- and HIF2α transgene-
overexpressed 46C ESCs with a luciferase-based TOP-Flash
(TCF optimal promoter) Wnt reporter plasmid, andcompared reporter activity in EBs at day 4. HIF2α signifi-
cantly enhanced reporter activity (2-fold; Figure 6A).
Accordingly, HIF2α increased the protein level of cytosol
β-catenin at day 4 (Figure 6B), suggesting that the
elevated β-catenin protein may contribute to the
cardiomyogenesis-promoting effect of HIF2α in ESCs.
To verify the impact of Wnt/β-catenin signaling on
HIF2α induced cardiac differentiation, two β-catenin
Figure 6 HIF2α-mediated ESC cardiac differentiation is β-catenin-dependent. (A) TOP Flash assay in PB- or PB-HIF2α- EBs at day 4. Data
represent the mean ± s.d. of three biological replicates. **p < 0.01 vs PB-EBs. (B) Western blot analysis of β-catenin at day 4 PB- or PB-HIF2α- EBs.
(C) TOP Flash assay of ESCs treated with the indicated conditions for 12 h. Data represent the mean ± s.d. of three biological replicates. **p < 0.01.
NT: No treatment. (D) The percentages of beating EBs derived from PB- or PB-HIF2α- ESCs in the presence or absence of 2 μm XAV939 or 2 μm
IWR1. Data represent the mean ± s.d. of three biological replicates. **p < 0.01. (E) qRT-PCR analysis of Gata4, Nkx2.5 and Mef2C in PB- or PB-HIF2α- EBs
in the presence or absence of 2 μm XAV939 or 2 μm IWR1. Data represent the mean ± s.d. of three biological replicates. **p < 0.01 vs PB.
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used to inhibit the activity of β-catenin (Figure 6C).
Inhibition of β-catenin significantly decreased the ac-
tivity of Wnt/β-catenin signaling in HIF2α overex-
pressed and knockdown cells (Figure 6C). Then, the
PB- and PB-HIF2α-transfected ESCs were incubated
with XAV939 and IWR1 during the process of differen-
tiation, and cardiac differentiation was assessed by cal-
culating the percentage of beating EBs and detecting
the cardiac cell markers Gata4, Nkx2.5 and Mef2c at
day 10. Compared with the no treatment (NT) group,
both inhibitors significantly reduced the number of
beating EBs and the expression of cardiac transcription
factors (Figures 6D and E). These results suggested that
HIF2α-mediated cardiogenesis is β-catenin-dependent in
ESCs.Indeed, the function of hypoxia is associated with
Wnt/β-catenin signaling in many types of cells. For ex-
ample, HIF1α promoted cellular adaptation to hypoxia
by interacting with β-catenin [32]. HIF2α accelerated cell
cycle progression and proliferation of renal cell carcin-
oma cells via binding β-catenin and enhancing its tran-
scriptional activity [33]. Further study found that HIF2α
could localize on the enhancer of Wnt10b as well as
upstream of the Wnt1 gene [34]. In cardiomyocyte de-
velopment, early hypoxia lead to activation of HIF1α
with potential subsequent effects on Wnt gene expres-
sion [29]. In our study, we also found that β-catenin is
required for HIF2α to promote cardiac formation. How-
ever, it is unclear whether HIF2α has the same effect on
β-catenin as HIF1α and how the latter affects β-catenin.
Meanwhile, it is noteworthy that there was no significant
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HIF2α sh#2 cells unlike that of PB and PB-HIF2α groups
(Figure 6C), implying other signaling pathways may be
responsible for the cardiomyogenesis–suppressing effect
of HIF2α knockdown. These detailed mechanisms need
to be clarified further.
Conclusions
The present results provide valuable insight on the func-
tion of HIF2α in ESC-derived cardiomyocytes. The
HIF2α-induced promoting effect on β-catenin signaling
may be involved in this process. Our results will be par-
ticularly helpful in attempts to achieve effective cardiac
differentiation from ESCs and will provide useful infor-
mation for the clinical application of ESCs.
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